The National MS Society’s Corporate Healthcare Roundtable serves as a forum for engagement of corporate healthcare partners and the National MS Society. Members of the Roundtable contribute to direct and focused dialogue with the purpose of collaborating on shared interests as well as addressing issues that directly impact the MS community.
The Corporate Healthcare Roundtable was developed with the goal to enhance collective impact through a common vision, shared resources, and continued commitment to ensure people affected by MS can live their best lives as we stop MS in its tracks, restore what has been lost and end MS forever.
Each year, members of the Corporate Healthcare Roundtable work collaboratively to develop an action plan or work toward a solution based on an identified topic and/or issue within the MS community.
Members of the Corporate Healthcare Roundtable will include representatives from healthcare organizations who have a shared commitment to all those affected by MS.
Members contribute to discussions by providing feedback, organizational focus, relevant non-proprietary information and contribute to actionable outcomes tasked by the Roundtable.
For more information on membership, please contact us.
2021 Corporate Healthcare Roundtable Consensus Statement
The 2021 Corporate Healthcare Roundtable is pleased to debut the Consensus Statement on Health Equity in Clinical Trials and Real-World Evidence Data Collection. This Consensus Statement demonstrates the collective commitment of the 2021 Roundtable members to addressing underrepresentation in clinical trials, including these principles in public policies, and practicing these principles as individual organizations and in partnership. Click here to view the statement and learn more.